Activation of SIRT1, a class III histone deacetylase, contributes to fructose feeding-mediated induction of the alpha-myosin heavy chain expression.
Fructose feeding has been shown to induce the cardiac alpha-myosin heavy chain (MHC) expression and protect the heart from ischemia- and reperfusion-mediated cell injury. This study was designed to investigate the mechanism involved in the effect of this sugar on MHC gene expression and cardiac protection. Adult mice were fed with a 6-propyl-2-thiouracil (PTU) diet or PTU combined with a fructose-rich diet. PTU treatment made animals hypothyroid and that resulted in total replacement of cardiac alpha-MHC with the beta-MHC isoform. Addition of fructose in the PTU diet led to reexpression of the alpha-MHC isoform to a significant level. Similar induction of alpha-MHC expression was also seen when PTU diet was combined with resveratrol, an agonist of sirtuin (SIRT) 1 deacetylase. Analysis of heart lysate of these animals indicated that fructose feeding augmented the NAD-to-NADH ratio and the cardiac SIRT1 levels, thus suggesting a role of SIRT1 in fructose-mediated activation of alpha-MHC isoform. To analyze a direct effect of SIRT1 on MHC isoform expression, we generated transgenic mice expressing SIRT1 in the heart. Treatment of these transgenic mice with PTU diet did not lead to disappearance of alpha-MHC, as it did in the nontransgenic animals. SIRT1 overexpression also activated the alpha-MHC gene promoter in transient transfection assays, thus confirming a role of SIRT1 in the induction of alpha-MHC expression. Fructose feeding also attenuated the MHC isoform shift and blocked the cardiac hypertrophy response associated with pressure overload, which was again associated with the induction of cardiac SIRT1 levels. These results demonstrate that fructose feeding protects the heart by induction of the SIRT1 deacetylase and highlight its role in the induction of alpha-MHC gene expression.
Pillai
Jyothish B
JB
Division of Cardiothoracic Surgery, Department of Surgery, Committee on Molecular Medicine and Pathology, The University of Chicago, Chicago, IL 60637, USA.
Chen
Martin
M
Rajamohan
Senthilkumar B
SB
Samant
Sadhana
S
Pillai
Vinodkumar B
VB
Gupta
Madhu
M
Gupta
Mahesh P
MP
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D013956:Antithyroid Agents / Q000494:pharmacology; D015153:Blotting, Western; D006332:Cardiomegaly / Q000201:enzymology / Q000503:physiopathology; D048429:Cell Size; D002478:Cells, Cultured; D003720:Densitometry; D004032:Diet; D004789:Enzyme Activation / Q000502:physiology; D005355:Fibrosis / Q000473:pathology; D005632:Fructose / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D009206:Myocardium / Q000378:metabolism; D018995:Myosin Heavy Chains / Q000096:biosynthesis* / Q000302:isolation & purification; D009243:NAD / Q000378:metabolism; D009747:Nutritional Physiological Phenomena; D011441:Propylthiouracil / Q000494:pharmacology; D012313:RNA / Q000096:biosynthesis / Q000302:isolation & purification; D000077185:Resveratrol; D056564:Sirtuin 1; D037761:Sirtuins / Q000235:genetics / Q000502:physiology*; D013267:Stilbenes / Q000494:pharmacology; D014162:Transfection
D000975:Antioxidants; D013956:Antithyroid Agents; D013267:Stilbenes; D009243:NAD; D005632:Fructose; D012313:RNA; D011441:Propylthiouracil; C470545:Sirt1 protein, mouse; D056564:Sirtuin 1; D037761:Sirtuins; D018995:Myosin Heavy Chains; D000077185:Resveratrol